Regenerative medicine, gene editing markets are growing

Regenerative medicine, gene editing markets are growing

When the U.S. Food and Drug Administration issued new guidance earlier this month on how companies who handle human cells, tissues and cellular and tissue-based products should report problems to the agency, it was a recognition that the medical industry is heading...